Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,781 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Yamasue H, Kojima M, Kuwabara H, Kuroda M, Matsumoto K, Kanai C, Inada N, Owada K, Ochi K, Ono N, Benner S, Wakuda T, Kameno Y, Inoue J, Harada T, Tsuchiya K, Umemura K, Yamauchi A, Ogawa N, Kushima I, Ozaki N, Suyama S, Saito T, Uemura Y, Hamada J, Kano Y, Honda N, Kikuchi S, Seto M, Tomita H, Miyoshi N, Matsumoto M, Kawaguchi Y, Kanai K, Ikeda M, Nakamura I, Isomura S, Hirano Y, Onitsuka T, Kosaka H, Okada T. Yamasue H, et al. Among authors: saito t. Brain. 2022 Apr 18;145(2):490-499. doi: 10.1093/brain/awab291. Brain. 2022. PMID: 35067719 Clinical Trial.
Risk factors for motor coordination problems in preschool-age children.
Suyama S, Yagyu K, Araki A, Miyashita C, Itoh S, Minatoya M, Yamazaki K, Tamura N, Nakai A, Saito T, Kishi R. Suyama S, et al. Among authors: saito t. Pediatr Int. 2020 Oct;62(10):1177-1183. doi: 10.1111/ped.14275. Pediatr Int. 2020. PMID: 32353913 Free article.
Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder.
Saito T, Yamashita Y, Tomoda A, Okada T, Umeuchi H, Iwamori S, Shinoda S, Mizuno-Yasuhira A, Urano H, Nishino I, Saito K. Saito T, et al. Among authors: saito k. BMC Psychiatry. 2020 Nov 10;20(1):530. doi: 10.1186/s12888-020-02932-2. BMC Psychiatry. 2020. PMID: 33167920 Free PMC article. Clinical Trial.
Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial.
Saito T, Ishida M, Nishiyori A, Ochiai T, Katagiri H, Matsumoto H. Saito T, et al. J Child Adolesc Psychopharmacol. 2022 Apr;32(3):132-142. doi: 10.1089/cap.2021.0104. Epub 2022 Mar 18. J Child Adolesc Psychopharmacol. 2022. PMID: 35319270 Clinical Trial.
Oxytocin-induced increases in cytokines and clinical effect on the core social features of autism: Analyses of RCT datasets.
Wakuda T, Benner S, Uemura Y, Nishimura T, Kojima M, Kuroda M, Matsumoto K, Kanai C, Inada N, Harada T, Kameno Y, Munesue T, Inoue J, Umemura K, Yamauchi A, Ogawa N, Kushima I, Suyama S, Saito T, Hamada J, Kano Y, Honda N, Kikuchi S, Seto M, Tomita H, Miyoshi N, Matsumoto M, Kawaguchi Y, Kanai K, Ikeda M, Nakamura I, Isomura S, Hirano Y, Onitsuka T, Ozaki N, Kosaka H, Okada T, Kuwabara H, Yamasue H. Wakuda T, et al. Among authors: saito t. Brain Behav Immun. 2024 May;118:398-407. doi: 10.1016/j.bbi.2024.03.013. Epub 2024 Mar 8. Brain Behav Immun. 2024. PMID: 38461957
Prevalence, incidence and persistence of ADHD drug use in Japan.
Okumura Y, Usami M, Okada T, Saito T, Negoro H, Tsujii N, Fujita J, Iida J. Okumura Y, et al. Among authors: saito t. Epidemiol Psychiatr Sci. 2019 Dec;28(6):692-696. doi: 10.1017/S2045796018000252. Epub 2018 May 28. Epidemiol Psychiatr Sci. 2019. PMID: 29804548 Free PMC article. No abstract available.
11,781 results
You have reached the last available page of results. Please see the User Guide for more information.